Industry Experts

Anna is a biochemist, former biotech founder, and commercialization leader with deep expertise in AI-driven drug discovery. Having most recently built and scaled commercial functions at the intersection of biology and technology, she is passionate about advancing new partnerships that enable access to highly performant GenAI tooling. At Converge, Anna is a business development lead for the company's suite platforms which span the drug discovery process end-to-end, from target discovery to antibody design, gene expression optimization, and biomarker discovery.